Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'POSTEXPOSURE TREATMENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Borak, J; Diller, WF
      Phosgene exposure: Mechanisms of injury and treatment strategies

      JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    2. Rotivel, Y; Goudal, M; de Fanti, AS
      Human rabies prophylaxis in France.

      MEDECINE ET MALADIES INFECTIEUSES
    3. Hanlon, CA; DeMattos, CA; DeMattos, CC; Niezgoda, M; Hooper, DC; Koprowski, H; Notkins, A; Rupprecht, CE
      Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis

      VACCINE
    4. Hanlon, CA; Niezgoda, M; Morrill, PA; Rupprecht, CE
      The incurable wound revisited: progress in human rabies prevention?

      VACCINE
    5. Sciuto, AM
      Posttreatment with ETYA protects against phosgene-induced lung injury by amplifying the glutathione to lipid peroxidation ratio

      INHALATION TOXICOLOGY
    6. Champion, JM; Kean, RB; Rupprecht, CE; Notkins, AL; Koprowski, H; Dietzschold, B; Hooper, DC
      The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure

      JOURNAL OF IMMUNOLOGICAL METHODS
    7. Quiambao, BP; Lang, J; Vital, S; Montalban, CG; Le Mener, V; Wood, SC; Miranda, E
      Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines

      ACTA TROPICA
    8. Sabchareon, A; Lang, J; Attanath, P; Sirivichayakul, C; Pengsaa, K; Le Mener, V; Chantavanich, P; Prarinyanuphab, V; Pojjaroen-Anant, C; Nimnual, S; Wood, SC; Riffard, P
      A new vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children

      CLINICAL INFECTIOUS DISEASES
    9. Sudre, P; Ruiz, DS; Fagard, C; Perrin, L; Hirschel, BJ
      HIV post-exposure prophylaxis (PEP): eligibility of sexually infected patients diagnosed at the time of primary infection

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    10. LANG J; GRAVENSTEIN S; BRIGGS D; MILLER A; FROESCHLE J; DUKES C; LEMENER V; LUTSCH C
      EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF A NEW, HEAT-TREATED HUMAN RABIES IMMUNE GLOBULIN USING A SHAM, POSTEXPOSURE PROPHYLAXIS OF RABIES

      Biologicals
    11. SABCHAREON A; CHANTAVANICH P; PASURALERTSAKUL S; POJJAROENANANT C; PRARINYANUPHARB V; ATTANATH P; SINGHASIVANON V; BUPPODOM W; LANG J
      PERSISTENCE OF ANTIBODIES IN CHILDREN AFTER INTRADERMAL OR INTRAMUSCULAR ADMINISTRATION OF PREEXPOSURE PRIMARY AND BOOSTER IMMUNIZATIONS WITH PURIFIED VERO CELL RABIES VACCINE

      The Pediatric infectious disease journal
    12. Lang, J; Simanjuntak, GH; Soerjosembodo, S; Koesharyono, C
      Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia

      BULLETIN OF THE WORLD HEALTH ORGANIZATION
    13. LANG J; ATTANATH P; QUIAMBAO B; SINGHASIVANON V; CHANTHAVANICH P; MONTALBAN C; LUTSCH C; PEPINCOVATTA S; LEMENER V; MIRANDA M; SABCHAREON A
      EVALUATION OF THE SAFETY, IMMUNOGENICITY, AND PHARMACOKINETIC PROFILEOF A NEW, HIGHLY PURIFIED, HEAT-TREATED EQUINE RABIES IMMUNOGLOBULIN,ADMINISTERED EITHER ALONE OR IN ASSOCIATION WITH A PURIFIED, VERO-CELL RABIES VACCINE

      Acta Tropica
    14. TSIANG H
      RABIES VACCINES - A REVIEW OF PROGRESS TOWARDS IMPROVED EFFICACY AND SAFETY

      Biodrugs
    15. BOTTIGER D; JOHANSSON NG; SAMUELSSON B; ZHANG H; PUTKONEN P; VRANG L; OBERG B
      PREVENTION OF SIMIAN IMMUNODEFICIENCY VIRUS, SIVSM, OR HIV-2 INFECTION IN CYNOMOLGUS MONKEYS BY PREEXPOSURE AND POSTEXPOSURE ADMINISTRATIONOF BEA-005

      AIDS
    16. PEREZ O; PAOLAZZI CC
      PRODUCTION METHODS FOR RABIES VACCINE

      Journal of industrial microbiology & biotechnology
    17. STRADY A; LANG J; ROTIVEL Y; JAUSSAUD R; FRITZELL C; TSIANG H
      RABIES IMMUNOPROPHYLAXIS - CURRENT RECOMM ENDATIONS

      La Presse medicale
    18. KHAWPLOD P; WILDE H; CHOMCHEY P; BENJAVONGKULCHAI M; YENMUANG W; CHAIYABUTR N; SITPRIJA V
      WHAT IS AN ACCEPTABLE DELAY IN RABIES IMMUNE GLOBULIN ADMINISTRATION WHEN VACCINE ALONE HAD BEEN GIVEN PREVIOUSLY

      Vaccine
    19. ERTL HCJ; XIANG ZQ
      NOVEL VACCINE APPROACHES

      The Journal of immunology
    20. XIANG ZQ; KNOWLES BB; MCCARRICK JW; ERTL HCJ
      IMMUNE EFFECTOR MECHANISMS REQUIRED FOR PROTECTION TO RABIES VIRUS

      Virology
    21. DIETZSCHOLD B
      MONOCLONAL-ANTIBODIES IN RABIES THERAPY

      CLINICAL IMMUNOTHERAPEUTICS
    22. HONG HA; ROOIJAKKERS EJM; KE NT; GROEN J; OSTERHAUS ADME
      METHODS FOR THE PURIFICATION OF EQUINE RABIES IMMUNOGLOBULIN - EFFECTS ON YIELD AND BIOLOGICAL-ACTIVITY

      Biologicals
    23. FESCHAREK R; FRANKE V; SAMUEL MR
      DO ANESTHETICS AND SURGICAL STRESS INCREASE THE RISK OF POSTEXPOSURE RABIES TREATMENT FAILURE

      Vaccine
    24. MONTANOHIROSE JA; LAFAGE M; WEBER P; BADRANE H; TORDO N; LAFON M
      PROTECTIVE ACTIVITY OF A MURINE MONOCLONAL-ANTIBODY AGAINST EUROPEAN BAT LYSSAVIRUS-1 (EBL1) INFECTION IN MICE

      Vaccine
    25. FISHBEIN DB; ROBINSON LE
      RABIES

      The New England journal of medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/21 alle ore 11:02:21